The present invention relates generally to medical devices and methods. More particularly, the invention relates to devices, systems and methods for enhancing cardiovascular valve repair, especially the repair of heart valves such as the mitral and tricuspid valves.
In recent years, many advances have been made to reduce the invasiveness of cardiac surgery. In an attempt to avoid open, stopped-heart procedures, which may be accompanied by high patient morbidity and mortality, many devices and methods have been developed for operating on a heart through smaller incisions, operating on a beating heart, and even performing cardiac procedures via transvascular access. Different types of cardiac procedures, such as cardiac ablation techniques for treating atrial fibrillation, stenting procedures for atherosclerosis, and valve repair procedures for treating conditions such as mitral valve regurgitation have experienced significant technological advances. In implementing many minimally invasive cardiac surgery techniques, especially beating-heart techniques, one of the most significant challenges is positioning a treatment device (or multiple devices) in a desired location in or around the heart for performing the procedure. Another challenge, once a device is positioned, is to effectively deploy a given treatment into or on the target cardiac tissue.
One type of cardiac surgery which may be from less invasive techniques is heart valve repair. Traditional treatment of heart valve stenosis or regurgitation, such as mitral or tricuspid regurgitation, typically involves an open-heart surgical procedure to replace or repair the valve. Valve repair procedures typically involve annuloplasty, a set of techniques designed to restore the valve annulus shape and strengthen the annulus. Conventional annuloplasty surgery generally requires a large incision into the thorax of the patient (a thoracotomy), and sometimes a median sternotomy (cutting through the middle of the sternum). These open heart, open chest procedures routinely involve placing the patient on a cardiopulmonary bypass machine for sustained periods so that the patient's heart and lungs can be artificially stopped during the procedure. Finally, valve pair and replacement procedures are typically technically challenging and require a relatively large incision through the wall of the heart to access the valve.
Due to the highly invasive nature of open heart valve repair or replacement, many patients, such as elderly patients, patients having recently undergone other surgical procedures, patients with comorbid medical conditions, children, late-stage heart patients, and the like, are often considered too high-risk to undergo heart valve surgery and are relegated to progressive deterioration and cardiac enlargement. Often, such patients have no feasible alternative treatments for their heart valve conditions.
To obviate this situation, a number of devices and methods for repairing cardiac valves in a less invasive manner have been described. Some devices provide for heart valve repair through minimally invasive incisions or intravascularly, while others improve upon open heart surgical procedures on beating hearts, stopped hearts or both. As mentioned above, difficulties in performing minimally invasive intracardiac surgery include positioning a minimally invasive treatment device in a desired location for performing a procedure and effectively deploying a given treatment into or on the target cardiac tissue. In heart valve repair procedures, for example, it is often essential for a physician to secure one or more treatment devices to valve annulus tissue. Annular tissue tends to be more fibrous than surrounding muscular or valve leaflet tissue, thus providing a more suitable location for securing such treatment devices, such as anchors, to treat a heart valve. Positioning an anchor deliver device in a desired location adjacent the annular tissue may often be challenging, especially intravascular procedure when visualization of the location is limited.
Devices and methods that address these difficulties are described in U.S. patent application Ser. Nos. 10/792,681, 10/741,130, 10/656,797, 10/461,043, 60/388,935, 60/429,288, 60/445,890, 60/462,502 and 60/524,622, which were previously incorporated by reference. For example, these references describe devices and methods for exposing, stabilizing and/or performing a procedure on a heart valve annulus, such as a mitral valve annulus. Many of the devices and methods previously described by the inventors have been found to be highly effective, but improvements are still being sought.
Therefore, it would be beneficial to have improved methods, devices and systems for enhancing heart valve annulus treatment procedures. Ideally, such methods, devices and systems would facilitate positioning of one or more devices in a left ventricle or elsewhere for performing a procedure on a heart valve annulus, visualizing the annulus and/or the like. Additionally, such methods, devices and systems would ideally be introduced intravascularly. At last some of these objectives will be met by the present invention.
Published U.S. Application Nos. 2002/0156526, 2003/0220685, 2004/0019378, 2004/0003819, 2004/0030382 and 2004/0039442, and U.S. Pat. Nos. 6,629,534 and 6,619,291 describe catheter-based methods for performing annuloplasty. Published U.S. Application 2002/0042621 describes a heart valve annuloplasty system with constrictable plication bands which are optionally attached to a linkage strip. Published U.S. Application 2002/0087169 describes a remote controlled catheter system which can be used to deliver anchors and a tether for performing annuloplasty procedure. Other patent publications of interest include WO01/26586; US2001/0005787; US2001/0014800; US2002/0013621; US2002/0029080; US2002/0035361; US2002/004262; US2002/0095167; and US2003/0074012. U.S. patents of interest include U.S. Pat. Nos. 4,014,492; 4,042,979; 4,043,504; 4,055,861; 4,700,250; 5,366,479; 5,450,860; 5,571,215, 5,674,279; 5,709,695; 5,752,518; 5,848,969; 5,860,992; 5,904,651; 5,961,539; 5,972,004; 6,165,183; 6,197,017; 6,250,308; 6,260,552; 6,283,993; 6,269,819; 6,312,447; 6,332,893, and 6,524,338. Publications of interest include De Simone et al. (1993) Am. J. Cardiol. 73:721-722, and Downing et al. (2001) Heart Surgery Forum, Abstract 7025. All of the above cited references are hereby incorporated by reference in the present application.
Devices, systems and methods of the present invention are generally used to facilitate transvascular, minimally invasive and other “less invasive” surgical procedures, by facilitating the delivery of treatment devices at a treatment site. “Less invasive,” for the purposes of this application, means any procedure that is less invasive than traditional, large-incision, open surgical procedures. Thus, a less invasive procedure may be an open surgical procedure involving one or more relatively small incisions, a procedure performed via transvascular percutaneous access, a transvascular procedure via cut-down, a laparoscopic or other endoscopic procedure, or the like. Generally, any procedure in which a goal is to minimize or reduce invasiveness to the patient may be considered less invasive. Furthermore, although the terms “less invasive” and “minimally invasive” may sometimes be used interchangeably in this application, neither these nor terms, used to describe a particular subset of surgical or other procedures should be interpreted to limit the scope of the invention. Generally, devices and methods of the invention may be used in performing or enhancing any suitable procedure.
The present application typically describes devices, systems and methods for performing heart valve repair procedures, and more specifically heart valve annuloplasty procedures such as mitral valve annuloplasty to treat mitral regurgitation. Devices and methods of the invention, however, may be used in any suitable procedure, both cardiac and non-cardiac. For example, they may be used in procedures to repair any heart valve, to repair an atrial-septal defect, to access and possibly perform a valve repair or other procedure from (or through) the coronary sinus, to place one or more pacemaker leads, to perform a cardiac ablation procedure such as ablating around pulmonary veins to treat atrial fibrillation, and/or the like. In other embodiments, the devices and methods may be used to enhance a laparoscopic endoscopic procedure on any part of the body, such as the bladder, stomach, gastroesophageal junction, vasculature, gall bladder the like. Therefore, although the following description typically focuses on mitral valve and other heart repair, such description should not be interpreted to limit the scope of the invention as defined by the claims.
That being said, the present invention generally provides devices, systems and methods for enhanced treatment of a cardiac valve annulus such as a mitral valve annulus. Methods generally involve contacting an anchor delivery device with a length of a valve annulus, delivering a plurality of coupled anchors from the anchor delivery device to secure the anchors to the annulus, and drawing the anchors together to circumferentially tighten the annulus. One device generally includes an elongate catheter having housing at or near the distal end for releasably housing a plurality of coupled anchors. The device may be positioned such that the housing abuts or is close to valve annular tissue, such as at an intersection of the left ventricular wall and one or more mitral valve leaflets of the heart. Some embodiments include self-securing anchors, which may change from undeployed to deployed configurations. Anchors may be drawn together to tighten the annulus by cinching a tether slidably coupled with the anchors and/or by a self-deforming member coupled with the anchors. Another device includes a steerable guide catheter for helping position the anchor delivery device for treating a valve annulus.
In many cases, methods of the present invention will be performed on a beating heart. Access to the beating heart may be accomplished by any available technique, including intravascular, transthoracic, and the like. Intravascular access to a heart valve may be achieved using any suitable route or method. To perform a procedure on a mitral valve, for example, in one embodiment a catheter may be advanced through a femoral artery, to the aorta, and into the left ventricle of the heart, to contact a length of the mitral valve. Alternatively, access may be gained through the venous system, to a central vein, into the right atrium of the heart, and across the interatrial septum to the left side of the heart to contact a length of the mitral valve. In either of these two types of intravascular access, the catheter will often easily be advanced, once it enters the left side of the heart, into a space defined by the left ventricular wall, one or more mitral valve leaflets, and chordae tendineae of the left ventricle. This space provides a convenient conduit for further advancement of the catheter to a desired location for performing mitral valve repair. In alternative embodiments, a catheter device may access the coronary sinus and a valve procedure may be performed directly from the sinus. Furthermore, in addition to beating heart access, methods of the present invention may be used for intravascular stopped heart access as well as stopped heart open chest procedures. Any suitable intravascular or other access method is contemplated within the scope of the invention.
In one aspect of the present invention, a method for advancing an operational device into a left ventricle of a heart to contact the mitral valve annulus comprises: advancing an operational device into a left ventricle and along at least a portion of a mitral valve annulus of a heart; urging the operational device radially outwardly to seat the operational device against the mitral valve annulus; the urging step being carried out at least in part by virtue of the operational device having a radius of curvature when in an expanded state larger than the radius of curvature of the mitral valve annulus; and acting on the mitral valve annulus by the operational device. In some embodiments, the radius of curvature of the operational device in the expanded state is about 25%-50% larger than the radius of curvature of the mitral valve annulus. Also in some embodiments, the advancing step is carried out in a retrograde manner into the left ventricle. For example, the advancing step may involve passing the operational device through the aorta.
In one embodiment, the urging step further comprises radially outwardly expanding an expansible element associated with the operational device. For example the radially outwardly expanding step may be carried out with an expansible element having a radius larger than the radius of the operational device. In some embodiments, the urging step thither comprises radially outwardly expanding a balloon associated with the operational device. Optionally, in some embodiments the urging step is carried out with an operational device having a length to seat the entire length of the operational device against the mitral valve annulus. The urging step may further comprise magnetically urging the operational device towards the mitral valve annulus. In some embodiments, the operational device advancing step is carried out using a steerable operational device.
In some embodiments, the operational device advancing step comprises: advancing a guide catheter into a left ventricle and along at least a portion of a mitral valve annulus of a heart; passing a flexible guide sheath over the guide catheter and along at least a portion of the mitral valve annulus; and advancing the operational device through the guide sheath. Optionally, the method may further include withdrawing the guide catheter from the guide sheath before advancing the operational device through the guide sheath. Some embodiments further include removing the guide the from the mitral valve annulus before the acting on step. In some embodiments the guide catheter advancing step is carried out using a steerable guide catheter.
In some embodiments, the acting on step comprises securing a series of anchors of the operational device to the mitral valve annulus, the series of anchors comprising a proximal anchor coupled to a tether and a distal anchor secured to the tether; and pulling on the tether to reduce the distance between the proximal and distal anchors. Optionally, the securing step may be carried out using self-forming anchors.
In one embodiment, the advancing step is carried out using an operational device comprising: an elongate housing having a longitudinal axis and an open interior; a self-forming forming tissue-engageable anchor within the open interior of the housing; the anchor having a first part and a second part, the second part having a tissue-piercing tip; the housing having an opening sized for passage of the anchor tip-first through the opening; the anchor placeable in a relatively straight, undeployed state generally parallel to the longitudinal axis within the housing; and the acting on step comprises driving the anchor tip-first through the opening with the anchor naturally assuming a curved, tissue-engaging deployed state after passing through the opening in the housing. Optionally, the advancing step may be carried out using an anchor comprising said first part and two of said second parts extending from the first part. In one embodiment, the second parts extend in directions generally opposite one another when in the deployed state. Alternatively, the second parts may have generally circular or semicircular shapes when in the deployed state.
In some embodiments, the anchor is oriented generally perpendicular to the longitudinal axis when in the deployed state. The anchor may also have a generally circular or semicircular shape when in the deployed state. In some embodiments, the advancing step is carried out using an operational device comprising: a series of the anchors, the anchors comprising a distal anchor and a proximal anchor; and a tether serially coupling the anchors to one another with the proximal anchor coupled to the tether and the distal anchor secured to the tether; and the acting on step comprises: securing the series of anchors to the mitral vial annulus; and pulling on the tether to reduce the distance between the proximal and distal anchors. Some embodiments further comprise selecting an operational device comprising a housing having a diametrical dimension d and an anchor having a diametrical dimension D in the deployed state, and wherein the ratio of D to d is at least 3.5. Other embodiments further comprise selecting an operational device comprising a housing having a diametrical dimension d and an anchor having a diametrical dimension D in the deployed state, and wherein the ratio of D to d is at least 4.4. Still other embodiments further comprise selecting an operational device comprising a housing having a diametrical dimension d and an anchor having a diametrical dimension D in the deployed state, and wherein the ratio of D to 4 is at least 7. Alternatively, the method may further comprise selecting an operational device comprising a housing having a diametrical dimension d and an anchor having a diametrical dimension D in the deployed state, and wherein the ratio of D is at least 8.8.
In some embodiments, the acting on step comprises deliver anchors from a housing of the operational device into tissue at the mitral valve annulus. In one embodiment, the anchors delivering step is carried out using a series of tethered anchors, comprising a tether and said anchors, and the acting on step further comprises circumferentially tightening the mitral valve annulus by placing the tether in tension. Optionally, the anchors delivering step may comprise driving at least one of the anchors through a biocompatible material thereby attaching the biocompatible material to the mitral valve annulus. In some embodiments, the anchor delivering step is carried out using a strip of the biocompatible material and the anchors driving step comprises driving a plurality of the anchors through the strip of biocompatible material. In some embodiments, the anchor delivering step is carried out using a plurality of pieces of the biocompatible material, and the anchors driving step comprises driving a plurality of the anchors through the pieces of biocompatible material.
In some embodiments, the advancing step comprises advancing the operational device through a guide sheath. The acting on step may also comprise delivering anchors from a housing of the operational device, through a distal portion of the guide sheath and into tissue at the mitral valve annulus thereby attaching the distal portion of the guide sheath to the mitral valve annulus. Optionally, the method may also comprise detaching the distal portion of the guide sheath from a proximal portion of the guide sheath. In some embodiments, the acting on step comprises delivering anchors from a housing of the operational device, through a distal portion of the operational device and into tissue the mitral valve annulus thereby attaching the distal portion of the operational device to the mitral valve annulus, and further comprising detaching the distal portion of the operational device from a proximal portion of the operational device.
In another aspect of the present invention, a method for advancing an operational device into a left ventricle of a heart to contact the mitral valve annulus comprises: advancing an operational device into a left ventricle and along at least a portion of a mitral valve annulus of a heart, the operational device comprising an expansible element; the operational device advancing step comprising steering the operational device; radially outwardly expanding the expansible element to urge the operational device radially outwardly to seat the operational device against the mitral valve annulus; and acting on the mitral valve annulus by the operational device. In some embodiments, the advancing step is carried out in a retrograde manner into the left ventricle. For example, the advancing step may comprise passing the operational device through the aorta.
In some embodiments, the radially outwardly expanding step is carried out with an expansible element having a radius larger than the radius of the operational device. Also in some embodiments, the urging step may be carried out with a balloon as the expansible element. The acting on step may optionally involve: securing series of anchors of the operational device to the mitral valve annulus, the series of anchors comprising a proximal anchor coupled to a tether and a distal anchor secured to the tether; and pulling on the tether to reduce the distance between the proximal and distal anchors. The securing step may be carried out, for example, using self-forming anchors. In other embodiments, the acting on step may involve delivering anchors from a housing of the operational device into tissue at the mitral valve annulus. For example, in one embodiment the anchors delivering step is carried out using a series of tethered anchors, comprising a tether and said anchors, and the acting on step further comprises circumferentially tightening the mitral valve annulus by placing the tether in tension.
In some embodiments, the acting on step comprises delivering anchors from a housing of the operational device, through a distal portion of the operational device and into tissue at the mitral valve annulus thereby attaching the distal portion of the operational device to the mitral valve annulus, and further comprising detaching the distal portion of the operational device from a proximal portion of the operational device. In some embodiments, the advancing step is carried out using the operational device as the only steerable element.
In another aspect of the invention, a method for advancing an operational device into a left ventricle of a heart to contact the mitral valve annulus comprises: advancing a guide catheter into a left ventricle and along at least a portion of a mitral valve annulus of a heart, the mitral valve annulus having a mitral valve annulus radius; selecting a flexible guide sheath having a curveable portion, said curveable portion having a guide sheath radius when in an outwardly expanded curved state, the guide sheath radius being larger than the mitral valve annulus radius; passing the guide sheath over the guide catheter and along at least a portion of the mitral valve annulus; urging the curveable portion of the guide sheath in the curved state towards the mitral valve annulus at least in part by virtue of the guide sheath radius; advancing an operational device through the guide sheath; and acting on the mitral valve annulus by the operational device. In some embodiments, the guide sheath radius is about 25%-50% larger than the mitral valve annulus radius. In some embodiments, the guide catheter advancing step is carried out using a steerable guide catheter.
In one embodiment, the method further comprises withdrawing the guide catheter from the guide sheath before the operational device advancing step. Some embodiments further comprise removing the guide sheath from the mitral valve annulus before the acting on step. The acting on step may optionally include urging the operational device radially outwardly to engage the mitral valve annulus. In some embodiments, the acting on step comprises: securing a series of anchors of the operational device, comprising a proximal anchor coupled to a tether and a distal anchor secured to the tether, to the mitral valve annulus; and pulling on the tether to reduce the distance between the proximal and distal anchors. In some embodiments, the securing step is carried out using self-forming anchors.
In another aspect of the present invention, a method for advancing an operational device into a left ventricle of a heart to contact the mitral valve annulus comprises: selecting a flexible guide catheter having a curveable portion, said curveable portion having a guide catheter radius when in outwardly expanded curved state; advancing the guide catheter into a left ventricle and along at least a portion of a mitral valve annulus of a heart, the mitral valve annulus having a mitral valve annulus radius; the selecting step being carried out with the guide catheter radius being larger than the mitral valve annulus radius; passing a curveable portion of the a guide sheath over the guide catheter and along at least a portion of the mitral valve annulus; urging the curveable portion of the guide sheath towards the mitral valve annulus at least in part by virtue of the guide catheter radius; advancing an operational device through the guide sheath; and acting on the mitral valve annulus by the operational device.
In some embodiments, the guide catheter radius is about 25%-50% larger than the mitral valve annulus radius. Optionally, the guide catheter advancing step is carried out using steerable guide catheter. The method may further include withdrawing the guide catheter from the guide sheath before the operational device advancing step. The method may also include removing the guide sheath from the mitral valve annulus before the acting on step. In some embodiments, the acting on step comprises urging the operational device radially outwardly to engage the mitral valve annulus. In some embodiments, the acting on step comprises: securing a series of anchors of the operational device, comprising a proximal anchor coupled to a tether and a distal anchor secured to the tether, to the mitral valve annulus; and pulling on the tether to reduce the distance between the proximal and distal anchors. In one embodiment, the securing step is carried out using self-forming anchors.
These and other aspects and embodiments are described more fully below with reference to the drawing figures.
Devices, systems and methods of the present invention are generally used to facilitate transvascular, minimally invasive and other “less invasive” surgical procedures, by facilitating the delivery of treatment devices at a treatment site. Although the following description focuses on use of devices and methods of the invention for mitral valve repair, the devices and methods may be used in any suitable procedure, both cardiac and non-cardiac. When used for treatment of a cardiac valve annulus, the inventive methods generally involve contacting an anchor delivery device with a length of the valve annulus, delivering a plurality of coupled anchors from the anchor delivery device, and drawing the anchors together to tighten the annulus. Devices include an elongate catheter having a housing at or near the distal end for releasably housing a plurality of coupled anchors, as well as delivery devices for facilitating advancement and/or positioning of an anchor delivery device. Devices may be positioned such that the housing abuts or is close to valve annular tissue, such as in a location within the left ventricle defined by the left ventricular wall, a mitral valve leaflet and chordae tendineae. Self-securing anchors having any of a number of different configurations may be used in some embodiments. Additional devices include delivery devices for facilitating delivery and/or placement of an anchor delivery device at a treatment site.
In many cases, methods of the present invention will be performed on a beating heart. Access to the beating heart may be accomplished by any available technique, including intravascular, transthoracic, and the like. In addition to beating heart access, the methods of the present invention may be used for intravascular stopped heart access as well as stopped heart open chest procedures.
Referring now to
In other embodiments, access to the heart H may be transathoracic, with delivery device 100 being introduced into the heart via an incision or port an the heart wall. Even open heart surgical procedures may benefit from methods and devices of the invention. Furthermore, some embodiments may be used to enhance procedures on the tricuspid valve annulus, adjacent the tricuspid valve leaflets TVL, or any other cardiac or vascular valve. Therefore, although the following description typically focuses on minimally invasive or less invasive mitral valve repair for treating mitral regurgitation, the invention is in no way limited to that use.
With reference now to
Distal portion 102 may be advanced into position under the valve annulus by any suitable technique, some of which are described below in further detail. Generally, distal portion 102 may be used to deliver anchors to the valve annulus, to stabilize and/or expose the annulus, or both. In one embodiment, using a delivery device having a flexible elongate body as shown in
In some embodiments, distal portion 102 includes a shape-changing portion which enables distal portion 102 to conform to the shape of the valve annulus VA. The catheter may be introduced through the vascular shape-changing distal portion in a generally straight, flexible configuration. Once it is in place beneath the leaflet at the intersection between the leaflet and the interior ventricular wall, the shape of distal portion 102 is changed to conform to the annulus and usually the shape is “locked” to provide sufficient stiffness or rigidity to permit the application of force from distal portion 102 to the annulus. Shaping and optionally locking distal portion 102 may be accomplished in any of a number of ways. For example, in some embodiments, a shape-changing portion may be sectioned, notched, slotted or segmented and one of more tensioning members such as tensioning cords, wires or other tensioning devices coupled with the shape-changing portion may be used to shape and rigidify distal portion 102. A segmented distal portion, for example, may include multiple segments coupled with two tensioning members, each providing a different direction of articulation to the distal portion. A first bend may be created by tensioning a first member to give the distal portion a C-shape or similar shape to conform to the valve annulus, while a second bend may be created by tensioning a second member to articulate the C-shaped member upwards against the annulus. In another embodiment, a shaped expandable member, such as a balloon, may be coupled with distal portion 102 to provide for shape changing/deforming. In various embodiments, any configuration and combinations may be used to give distal portion 102 a desired shape.
In transthoracic and other embodiments, distal portion 102 may be shaped, and the method may simply involve introducing distal portion 102 under the valve leaflets. The shaped distal portion 102 may be rigid or formed from any suitable super-elastic or shape memory material, such as nitinol, spring stainless steel, or the like.
In addition to delivering, anchors to the valve annulus VA, delivery device 100 (and specifically distal portion 102) may be used to stabilize and/or expose the valve annulus VA. Such stabilization and exposure are described fully in U.S. patent application Ser. No. 10/656,797, which was previously incorporated by reference. For example, once distal portion 102 is positioned under the annulus, force may be applied to distal portion 102 to stabilize the valve annulus VA, as shown in
Some embodiments may include a stabilization component as well as an anchor delivery component. For example, some embodiments may include two flexible members, one for contacting the atrial side of a valve annulus and the other for contacting the ventricular side. In some embodiments, such flexible members may be used to “clamp” the annulus between them. One of such members may be an anchor delivery member and the other may be a stabilization member, for example. Any combination and configuration of stabilization and/or anchor delivery members is contemplated.
Referring to
Although delivery device 108 is shown having a circular cross-sectional shape in
With reference to
Housing 206 may be flexible or rigid in various embodiments. In some embodiments, for example, flexible housing 206 may be comprised of multiple segments configured such that housing 206 is deformable by tensioning a tensioning member coupled to the segments. In some embodiments, housing 206 is formed from an elastic material having a geometry selected to engage and optionally shape or constrict the valve annulus. For example, the rings may be formed from super-elastic material, shape memory alloy such as Nitinol, spring stainless steel, or the like. In other instances, housing 206 could be formed from an inflatable or other structure can be selectively rigidified in situ, such as a gooseneck or lockable element shaft, any of the rigidifying structures described above, or any other rigidifying structure.
“Anchors,” for the purposes of this application, is defined to mean any fasteners. Thus, anchors 210 may comprise C-shaped or semicircular hooks, curved hooks of other shapes, straight hooks, barbed hooks, clips of any kind, T-tags, or any other suitable fastener(s). In one embodiment, as described above, anchors may comprise two tips that curve in opposite directions upon deployment, forming two intersecting semi-circles, circles, ovals, helices or the like. In some embodiments, anchors 210 are self-deforming. By “self-deforming” it is meant that anchors 210 change from a first undeployed shape to a second deployed shape upon release of anchors 210 from restraint in housing 206. Such self-deforming anchors 210 may change shape as they are released from housing 206 and enter valve annulus tissue, to secure themselves to the tissue. Thus, a crimping device or other similar mechanism is not required on distal end 202 to apply force to anchors 210 to attach them to annular tissue.
Self-deforming anchors 210 may be made of any suitable material, such as a super-elastic or shape-memory material like Nitinol or spring stainless steel. In other embodiments, anchors 210 may be made of a non-shape-memory material and made be loaded into housing 206 in such a way that they change shape upon release. Alternatively, anchors 210 that are not self-deforming may be used, and such anchors may be secured to tissue via crimping, firing or the like. Even self-securing anchors may be crimped in some embodiments, to provide enhanced attachment to tissue. In some embodiments, anchors 210 may comprise one or more bioactive agent. In another embodiment, anchors 210 may comprise electrodes. Such electrodes, for example, may sense various parameters, such as but not limited to impedance, temperature and electrical signals. In other embodiments, such electrodes may be used to supply energy to tissue at ablation or sub-ablation amounts. Delivery of anchors may be accomplished by any suitable device and technique, such as by simply releasing the anchors by hydraulic balloon delivery as discussed further below. Any number, size and shape of anchors 210 may be included in housing 206.
In one embodiment, anchors 210 are generally C-shaped or semicircular in their undeployed form, with the ends of the C being sharpened to penetrate tissue. Midway along the C-shaped anchor 210, an eyelet may be formed for allowing slidable passage of tether 212. To maintain anchors 210 in their C-shaped, undeployed state, anchors 210 may be retained within housing 206 by two mandrels 214, one mandrel 214 retaining each of the two arms of the C-shape of each anchor 210. Mandrels 214 may be retractable within elongate catheter body 204 to release anchors 210 and allow them to change from their undeployed C-shape to a deployed shape. The deployed shape, for example, may approximate a complete circle or a circle with overlapping ends, the latter appearing similar to a key ring. Such anchors are described further below, but generally may be advantageous in their ability to secure themselves to annular tissue by changing from their undeployed to their deployed shape. In some embodiments, anchors 210 are also configured to lie flush with a tissue surface after being deployed. By “flush” it is meant that no significant amount of an anchor protrudes from the surface, although some small portion may protrude.
Tether 212 may be one long piece of material or two or more pieces and may comprise any suitable material, such as suture, suture-like material, a Dacron strip or the like. Retaining mandrels 214 may also have any suitable configuration and be made of any suitable material, such as stainless steel, titanium, Nitinol, or the like. Various embodiments may have one mandrel, two mandrels, or more than two mandrels.
In some embodiments, anchors 210 may be released from mandrels 214 to contact and secure themselves to annular tissue without any further force applied by delivery device 200. Some embodiments, however, may also include one or more expandable members 208, which may be expanded to help drive anchors 210 into tissue. Expandable members 208 may have any suitable size, and configuration and may be made of any suitable material(s). Hydraulic systems such as expandable members are known in the art, and any known or as yet undiscovered expandable member may be included in housing 206 as part of the present invention.
Referring now to
With reference now to
Referring to
In
With reference now to
Referring now to
In the embodiment shown in
Retracting contacting member 530 to push anchors 526 out of apertures help cause anchors 526 to avidly secure themselves to adjacent tissue. Using anchors 526 that are relatively straight/flat when undeployed allows anchors 526 with relatively large deployed sizes to be disposed in (and delivered from) a relatively small housing 522. In one embodiment, for example, anchors 526 that deploy into a shape approximating two intersecting semi-circles circles, ovals, helices, or the like, and that have a radius of one of the semi-circles of about 3 mm may be disposed within a housing 522 having a diameter of about 5 French (1.67 min) and more preferably 4 French (1.35 mm) or even smaller. Such anchors 526 may measure about 6 mm or more in their widest dimension. In some embodiments, housing 522 may have a diametrical dimension (“d”) and anchor 526 may have a diametrical dimension (“D”) in the deployed state, and the ratio of D to d may be at least about 3.5. In other embodiments, the ratio of D to d may be at least about 4.4, and more preferably at least about 7, even more preferably at least about 8.8. These are only examples, however, and other larger or smaller anchors 526 may be disposed a within a larger or smaller housing 522. Furthermore, any convenient number of anchors 526 may be disposed within housing 522. In one embodiment, for example, housing 522 may hold about 1-20 anchors 526, and, more preferably about 3-10 anchors 526. Other embodiments may hold more anchors 526.
Anchor contacting member 530 and pull cord 532 may have any suitable configuration and may be manufactured from any material or combination of materials. In alternative embodiments, contacting member 530 may be pushed by a pusher member to contact and deploy anchors 526. Alternatively, any of the anchor deployment devices and methods previously described may be used.
Tether 534, as shown in
Expandable member 524 is an optional feature of anchor delivery device 520, and thus may be included in some embodiments and not in others. In other words, a distal portion of anchor delivery device 520 may include housing, contents of housing, and other features either with or without an attached expandable member. Expandable member 524 may comprise any suitable expandable member currently known or discovered in the future, and any method and substance(s) may, be used to expand expandable member 524. Typically, expandable member 524 will be coupled with a surface of housing 522, will have a larger radius than housing 522, and will be configured such that when it is expanded as housing 522 nears or contacts the valve annulus, expandable member 524 will push or press housing 522 into enhanced contact with the annulus. For example, expandable member 524 may be configured to expand within a space near the corner formed by a left ventricular wall and a mitral valve leaflet.
With reference now to
Generally, delivery device 520 may be advanced into any suitable location for treating any valve by any suitable advancing or device placement method. Many catheter-based, minimally invasive devices and methods for performing intravascular procedures, for example, are well known, and any such devices and methods, as well as any other devices or method later developed, may be used to advance or position delivery device 520 in a desired location. For example, in one embodiment a steerable guide catheter is first advanced in retrograde fashion through an aorta, typically via access from a femoral artery. The steerable catheter is passed into the left ventricle of the heart and thus into the space formed by the mitral valve leaflets, the left ventricular wall and cordae tendineae of the left ventricle. Once in this space, the steerable catheter is easily advanced along a portion (or all) of the circumference of the mitral valve. A sheath is advanced over the steerable catheter within the space below the valve leaflets, and the steerable catheter is removed through the sheath. Anchor delivery device 520 may then be advanced through the sheath to a desired position within the space, and the sheath may be removed. In some cases, an expandable member coupled to delivery device 520 may be expanded to wedge or otherwise move delivery device 520 into the corner formed by the left ventricular wall and the valve leaflets to enhance its contact with the valve annulus. Of course, this is but one exemplary method for advancing delivery device 520 to a position for treating a valve, and any other suitable method, combination of devices, etc. may be used.
As shown in
Referring now to
In one embodiment, cinching tether 534, attaching tether 534 to most-proximal anchor 526, and cutting tether 534 are achieved using a termination device (not shown). The termination device may comprise, for example, a catheter advancable over tether 534 that includes a cutting member and a nitinol knot or other attachment member for attaching tether 534 to most-proximal anchor. The termination catheter may be advanced over tether 534 to a location at or near the proximal end of the tethered anchors 526. It may then be used to apply opposing force to the most-proximal anchor 526 while tether 534 is cinched. Attachment and cutting members may then be used to attach tether 534 to most-proximal anchor 526 and cut tether 534 just proximal to most-proximal anchor 526. Such a termination device is only one possible way of accomplishing the cinching, attachment and cutting steps, and any other suitable device(s) or technique(s) may be used.
In some embodiments, it may be advantageous to deploy a first number of anchors 526 along a first portion of a valve annulus VA, cinch the first anchors to tighten that portion of the annulus, move the delivery device 520 to another portion of the annulus, and deploy and cinch a second number of anchors 526 along a second portion of the annulus. Such a method may be more convenient, in some cases, than extending delivery device 520 around all or most of the circumference of the annulus, and may allow a shorter, more maneuverable housing 522 to be used.
In an embodiment similar to that shown in
In another embodiment, a distal portion of delivery device 520 may be detachable from a proximal portion of delivery device 520. Such an embodiment may be configured such that when anchors 526 are deployed from device 520, the distal portion of device 520 detaches from the proximal portion and is attached, via anchors 526, to the valve annulus VA. In one embodiment, for example, anchors 526 may pierce through the distal portion of device 520, rather than exiting device 520 through apertures 528. The distal portion may be detachable via any suitable means, such as perforations or the like.
Referring now to
With reference now to
In a number of cases, and with reference now to
In an alternative embodiment, pictured in
As shown in
Referring now to
A number of different variations of locking members are contemplated in various embodiments. For example, a two-pronged member may be used, with the prongs deployable from a delivery position to and expanded configuration, and with the prongs optionally engaging with the terminal anchor 710. In another embodiment, multiple prongs may be aligned in a linear fashion along a locking member, such as in a rake-like configuration. Yet another embodiment include two prongs for engaging with the terminal anchor 710 and another prong for engaging with valve annulus tissue VA. Thus, any of a number of different embodiments may be employed as part of the present invention. Such locking members may be constructed from any suitable material or combination of materials, such as Nitinol, spring stainless steel and/or other shape memory or super-elastic materials.
Next, as in
In various embodiments, alternative means may be used to urge anchor delivery device 558 into contact with the valve annulus. For example, in one embodiment an expandable member is coupled with anchor delivery device 558 and expanded within the subannular space 552. In an alternative embodiment, a magnet may be coupled with anchor delivery device 558, and another anchor may be disposed within the coronary sinus, in proximity to the first magnet. The two magnets may attract one another, thus pulling the anchor delivery device 558 into greater contact with the annulus. In another embodiment, anchor delivery device 558 in an expanded (or deployed) state may have a radius of curvature that is larger than the radius of curvature of the mitral valve annulus, thus causing device 558 to be urged against the annulus. In one embodiment, for example, the radius of curvature of device 558 in the expanded/deployed state is about 25%-50% larger than the radius of curvature of the mitral valve annulus.
Various embodiments include visualizing the annulus using a visualization member coupled with the anchor delivery device 558 or separate from the device 558. In some embodiments, anchors may be driven through a strip of detachable, biocompatible material, such as Dacron, that is coupled with anchor delivery device 558 but that detaches to affix to the valve annulus via the anchors. In some embodiments, the strip may then be cinched to tighten the annulus. In other embodiments, the anchors may be driven through a detachable, biocompatible, distal portion of the guide sheath 556, and guide sheath 556 may then remain attached to the annulus via the anchors. Again, in some embodiments, the detached sheath may be cinched to tighten the annulus.
Of course, the method just described is but one embodiment of a method for delivering an anchor delivery device to a location for treating a valve annulus. In various alternative embodiments, one or more steps may be added, deleted or modified while achieving a similar result. In some embodiments, a similar method may be used to treat the mitral valve from a superior/right atrial position or to treat another heart valve. Additionally, other devices or modifications of the system just described may be used in other embodiments.
With reference now to
Generally, proximal portion 562 of the catheter body is less flexible than distal portion 544. Proximal portion 562 may be made of any suitable material, such as PEBAX, FEP, nylon, polyethylene and/or the like, and may include a braided material, such as stainless steel, to provide stiffness and strength. Distal portion 564 may be made of similar or other materials, but the braided material is typically not included, to provide for greater flexibility. Both proximal and distal portions 562/564 may have any suitable lengths, diameters, overall configurations and the like. In one embodiment the catheter body is approximately 140 cm in length and 6 French in diameter, but any other suitable sizes may be used in other embodiments. Either proximal portion 562, distal portion 564 or preferably both, may be made from or coated with one or more friction resistant or lubricating material to enhance passage of device 560 through an introducer catheter and/or to enhance passage of a sheath or other device over catheter device 560.
With reference now to
In the embodiments just described or in alternative embodiments, tissue anchors may also have one or more features designed to enhance ingrowth and/or encapsulation of the anchors into annular tissue. Such features, for example, may include a coating, a porous and/or rough surface, an attachment such as a polyester band or belt, or any other suitable surface feature or added feature. By promoting encapsulation of tissue anchors, attachment strength of the anchors to tissue is enhanced.
Referring now to
In an alternative embodiment, as shown in
Referring now to
With reference now to
Although the foregoing is a complete and accurate description of the present invention, the description provided above is for exemplary purposes only, and variations may be made to the embodiments described without departing from the scope of the invention. Thus, the above description should not be construed to limit the scope of the invention as described in the appended claims.
The present application is a continuation of U.S. patent application Ser. No. 14/626,826, filed Feb. 19, 2015, now issued as U.S. Pat. No. 9,949,829, which is a continuation of U.S. patent application Ser. No. 10/901,554, filed on Jul. 27, 2004, now issued as U.S. Pat. No. 9,226,825, which is a continuation-in-part of U.S. patent application Ser. No. 10/792,681, filed on Mar. 2, 2004, now abandoned, which is a continuation-in-part of U.S. patent application Ser. No. 10/741,130, filed on Dec. 19, 2003, now issued as U.S. Pat. No. 8,287,555, which claims the benefit of U.S. Provisional Patent Application Nos. 60/459,735, filed on Apr. 1, 2003 and 60/524,922, filed Nov. 24, 2003, and which is a continuation-in-part of U.S. patent application Ser. No. 10/656,797, filed on Sep. 4, 2003, now issued as U.S. Pat. No. 7,753,922, and Ser. No. 10/461,043, filed on Jun. 13, 2003, now issued as U.S. Pat. No. 6,986,775, the latter of which claims the benefit of U.S. Provisional Patent Application Nos. 60/388,935, filed on Jun. 13, 2002; 60/429,288, filed on Nov. 25, 2002; 60/445,890, filed on Feb. 6, 2003; 60/462,502, filed on Apr. 10, 2003. The full disclosures of all of the above-listed references are hereby incorporated by reference. The present application is related to U.S. patent application Ser. No. 10/901,019, filed on Jul. 27, 2004; Ser. No. 10/900,980, filed on Jul. 27, 2004 Ser. No. 10/901,444, filed on Jul. 27, 2004; Ser. No. 10/901,455, filed on Jul. 27, 2004; and Ser. No. 10/901,555, filed on Jul. 27, 2004, all of which are hereby fully incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
2108206 | Meeker | Feb 1938 | A |
3656185 | Carpentier | Apr 1972 | A |
3727614 | Kniazuk | Apr 1973 | A |
3773034 | Burns et al. | Nov 1973 | A |
3837345 | Matar | Sep 1974 | A |
3961419 | Schwartz | Jun 1976 | A |
3976079 | Samuels et al. | Aug 1976 | A |
4014492 | Rothfuss | Mar 1977 | A |
4034473 | May | Jul 1977 | A |
4042979 | Angell | Aug 1977 | A |
4043504 | Hueil et al. | Aug 1977 | A |
4053979 | Tuthill et al. | Oct 1977 | A |
4055861 | Carpentier et al. | Nov 1977 | A |
4069825 | Akiyama | Jan 1978 | A |
4290151 | Massana | Sep 1981 | A |
4384406 | Tischlinger | May 1983 | A |
4445892 | Hussein et al. | May 1984 | A |
4489446 | Reed | Dec 1984 | A |
4494542 | Lee | Jan 1985 | A |
4619247 | Inoue et al. | Oct 1986 | A |
4700250 | Kuriyama | Oct 1987 | A |
4726371 | Gibbens | Feb 1988 | A |
4758221 | Jureidini | Jul 1988 | A |
4784133 | Mackin | Nov 1988 | A |
4798594 | Hillstead | Jan 1989 | A |
4845851 | Warthen | Jul 1989 | A |
4848341 | Ahmad | Jul 1989 | A |
4850354 | McGurk-Burleson et al. | Jul 1989 | A |
4961738 | Mackin | Oct 1990 | A |
4969893 | Swor | Nov 1990 | A |
4976710 | Mackin | Dec 1990 | A |
5053047 | Yoon | Oct 1991 | A |
5064431 | Gilbertson et al. | Nov 1991 | A |
5078731 | Hayhurst | Jan 1992 | A |
5084058 | Li | Jan 1992 | A |
5103804 | Abele et al. | Apr 1992 | A |
5108368 | Hammerslag et al. | Apr 1992 | A |
5133723 | Li et al. | Jul 1992 | A |
5221255 | Mahurkar et al. | Jun 1993 | A |
5221269 | Miller et al. | Jun 1993 | A |
5242456 | Nash et al. | Sep 1993 | A |
5242457 | Akopov et al. | Sep 1993 | A |
5257975 | Foshee | Nov 1993 | A |
5306296 | Wright et al. | Apr 1994 | A |
5312341 | Turi | May 1994 | A |
5324298 | Phillips et al. | Jun 1994 | A |
5346500 | Suchart | Sep 1994 | A |
5358479 | Wilson | Oct 1994 | A |
5358514 | Schulman et al. | Oct 1994 | A |
5364407 | Poll | Nov 1994 | A |
5366479 | McGarry et al. | Nov 1994 | A |
5368591 | Lennox et al. | Nov 1994 | A |
5372604 | Trott | Dec 1994 | A |
5383905 | Golds et al. | Jan 1995 | A |
5409483 | Campbell et al. | Apr 1995 | A |
5409499 | Yi | Apr 1995 | A |
5417700 | Egan | May 1995 | A |
5423837 | Mericle et al. | Jun 1995 | A |
5437680 | Yoon | Aug 1995 | A |
5439470 | Li | Aug 1995 | A |
5450860 | O'Connor | Sep 1995 | A |
5452513 | Zinnbauer et al. | Sep 1995 | A |
5474572 | Hayhurst | Dec 1995 | A |
5507760 | Wynne et al. | Apr 1996 | A |
5520702 | Sauer et al. | May 1996 | A |
5522873 | Jackman et al. | Jun 1996 | A |
5524630 | Crowley | Jun 1996 | A |
5527323 | Jervis et al. | Jun 1996 | A |
5531686 | Lundquist et al. | Jul 1996 | A |
5545134 | Hilaire et al. | Aug 1996 | A |
5545168 | Burke | Aug 1996 | A |
5565122 | Zinnbauer et al. | Oct 1996 | A |
5571215 | Sterman et al. | Nov 1996 | A |
5591194 | Berthiaume | Jan 1997 | A |
5626590 | Wilk | May 1997 | A |
5626614 | Hart | May 1997 | A |
5630824 | Hart | May 1997 | A |
5643289 | Sauer et al. | Jul 1997 | A |
5669917 | Sauer et al. | Sep 1997 | A |
5674279 | Wright et al. | Oct 1997 | A |
5690655 | Hart et al. | Nov 1997 | A |
5709695 | Northrup, III | Jan 1998 | A |
5713950 | Cox | Feb 1998 | A |
5716370 | Williamson, IV et al. | Feb 1998 | A |
5718725 | Sterman et al. | Feb 1998 | A |
5725542 | Yoon | Mar 1998 | A |
5733308 | Daugherty et al. | Mar 1998 | A |
5735290 | Sterman et al. | Apr 1998 | A |
5741260 | Songer et al. | Apr 1998 | A |
5741301 | Pagedas | Apr 1998 | A |
5752518 | McGee et al. | May 1998 | A |
5752964 | Mericle | May 1998 | A |
5752966 | Chang | May 1998 | A |
5755730 | Swain et al. | May 1998 | A |
5766240 | Johnson | Jun 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5782861 | Cragg et al. | Jul 1998 | A |
5810848 | Hayhurst | Sep 1998 | A |
5810853 | Yoon | Sep 1998 | A |
5817107 | Schaller | Oct 1998 | A |
5827171 | Dobak, III et al. | Oct 1998 | A |
5843169 | Taheri | Dec 1998 | A |
5848969 | Panescu et al. | Dec 1998 | A |
5860992 | Daniel et al. | Jan 1999 | A |
5860993 | Thompson et al. | Jan 1999 | A |
5868733 | Ockuly et al. | Feb 1999 | A |
5879371 | Gardiner et al. | Mar 1999 | A |
5885238 | Stevens et al. | Mar 1999 | A |
5888240 | Carpentier et al. | Mar 1999 | A |
5902321 | Caspari et al. | May 1999 | A |
5904651 | Swanson et al. | May 1999 | A |
5906579 | Vander Salm et al. | May 1999 | A |
5911717 | Jacobsen et al. | Jun 1999 | A |
5919208 | Valenti | Jul 1999 | A |
5935149 | Ek | Aug 1999 | A |
5947983 | Solar et al. | Sep 1999 | A |
5961440 | Schweich, Jr. et al. | Oct 1999 | A |
5961539 | Northrup, III et al. | Oct 1999 | A |
5972004 | Williamson, IV et al. | Oct 1999 | A |
5984933 | Yoon | Nov 1999 | A |
5989284 | Laufer | Nov 1999 | A |
5991650 | Swanson et al. | Nov 1999 | A |
6010531 | Donlon et al. | Jan 2000 | A |
6015428 | Pagedas | Jan 2000 | A |
6045497 | Schweich, Jr. et al. | Apr 2000 | A |
6050936 | Schweich, Jr. et al. | Apr 2000 | A |
6042534 | Gellman et al. | May 2000 | A |
6059715 | Schweich, Jr. et al. | May 2000 | A |
6066160 | Colvin et al. | May 2000 | A |
6074401 | Gardiner et al. | Jun 2000 | A |
6077214 | Mortier et al. | Jun 2000 | A |
6077989 | Kandel et al. | Jun 2000 | A |
6099553 | Hart et al. | Aug 2000 | A |
6102945 | Campbell | Aug 2000 | A |
6125852 | Stevens et al. | Oct 2000 | A |
6149658 | Gardiner et al. | Nov 2000 | A |
6152934 | Harper et al. | Nov 2000 | A |
6162168 | Schweich, Jr. et al. | Dec 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6171317 | Jackson et al. | Jan 2001 | B1 |
6171329 | Shaw et al. | Jan 2001 | B1 |
6183469 | Thapliyal et al. | Feb 2001 | B1 |
6197017 | Brock et al. | Mar 2001 | B1 |
6200329 | Fung et al. | Mar 2001 | B1 |
6221084 | Fleenor | Apr 2001 | B1 |
6228055 | Foerster et al. | May 2001 | B1 |
6228096 | Marchand | May 2001 | B1 |
6250308 | Cox | Jun 2001 | B1 |
6254620 | Koh et al. | Jul 2001 | B1 |
6258118 | Baum et al. | Jul 2001 | B1 |
6260552 | Mortier et al. | Jul 2001 | B1 |
6269819 | Oz et al. | Aug 2001 | B1 |
6283993 | Cosgrove et al. | Sep 2001 | B1 |
6306149 | Meade | Oct 2001 | B1 |
6312447 | Grimes | Nov 2001 | B1 |
6328727 | Frazier et al. | Dec 2001 | B1 |
6332893 | Mortier et al. | Dec 2001 | B1 |
6355030 | Aldrich et al. | Mar 2002 | B1 |
6378289 | Trudeau et al. | Apr 2002 | B1 |
6391048 | Ginn et al. | May 2002 | B1 |
6406420 | McCarthy et al. | Jun 2002 | B1 |
6409743 | Fenton, Jr. | Jun 2002 | B1 |
6423088 | Fenton, Jr. | Jul 2002 | B1 |
6432123 | Schwartz et al. | Aug 2002 | B2 |
6461327 | Addis et al. | Oct 2002 | B1 |
6514265 | Ho et al. | Feb 2003 | B2 |
6524338 | Gundry | Feb 2003 | B1 |
6533753 | Haarstad et al. | Mar 2003 | B1 |
6551332 | Nguyen et al. | Apr 2003 | B1 |
6575971 | Hauck et al. | Jun 2003 | B2 |
6575987 | Gellman et al. | Jun 2003 | B2 |
6589160 | Schweich, Jr. et al. | Jul 2003 | B2 |
6602288 | Cosgrove et al. | Aug 2003 | B1 |
6602289 | Colvin et al. | Aug 2003 | B1 |
6607541 | Gardiner et al. | Aug 2003 | B1 |
6613059 | Schaller et al. | Sep 2003 | B2 |
6619291 | Hlavka et al. | Sep 2003 | B2 |
6626899 | Houser et al. | Sep 2003 | B2 |
6626910 | Hugues | Sep 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6641593 | Schaller et al. | Nov 2003 | B1 |
6648903 | Pierson, III | Nov 2003 | B1 |
6651671 | Donlon et al. | Nov 2003 | B1 |
6655386 | Makower et al. | Dec 2003 | B1 |
6669687 | Saadat | Dec 2003 | B1 |
6676702 | Mathis | Jan 2004 | B2 |
6689164 | Seguin | Feb 2004 | B1 |
6699263 | Cope | Mar 2004 | B2 |
6702826 | Liddicoat et al. | Mar 2004 | B2 |
6716243 | Colvin et al. | Apr 2004 | B1 |
6718985 | Hlavka et al. | Apr 2004 | B2 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6723107 | Skiba et al. | Apr 2004 | B1 |
6733509 | Nobles et al. | May 2004 | B2 |
6746457 | Dana et al. | Jun 2004 | B2 |
6749622 | McGuckin et al. | Jun 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6790231 | Liddicoat et al. | Sep 2004 | B2 |
6793618 | Schweich, Jr. et al. | Sep 2004 | B2 |
6802851 | Jones et al. | Oct 2004 | B2 |
6811560 | Jones et al. | Nov 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6875224 | Grimes | Apr 2005 | B2 |
6908424 | Mortier et al. | Jun 2005 | B2 |
6923818 | Muramatsu et al. | Aug 2005 | B2 |
6932792 | St. Goar et al. | Aug 2005 | B1 |
6986775 | Morales et al. | Jan 2006 | B2 |
6991643 | Saadat | Jan 2006 | B2 |
6997931 | Sauer et al. | Feb 2006 | B2 |
7004958 | Adams et al. | Feb 2006 | B2 |
7037334 | Hlavka et al. | May 2006 | B1 |
7044957 | Foerster et al. | May 2006 | B2 |
7048754 | Martin et al. | May 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7125421 | Tremulis et al. | Oct 2006 | B2 |
7166127 | Spence et al. | Jan 2007 | B2 |
7186262 | Saadat | Mar 2007 | B2 |
7186264 | Liddicoat et al. | Mar 2007 | B2 |
7189199 | McCarthy et al. | Mar 2007 | B2 |
7235086 | Sauer et al. | Jun 2007 | B2 |
7241310 | Taylor et al. | Jul 2007 | B2 |
7326231 | Phillips et al. | Feb 2008 | B2 |
7335213 | Hyde et al. | Feb 2008 | B1 |
7344544 | Bender et al. | Mar 2008 | B2 |
7452325 | Schaller | Nov 2008 | B2 |
7534204 | Starksen et al. | May 2009 | B2 |
7588582 | Starksen et al. | Sep 2009 | B2 |
7618449 | Tremulis et al. | Nov 2009 | B2 |
7655040 | Douk et al. | Feb 2010 | B2 |
7666193 | Starksen et al. | Feb 2010 | B2 |
7727247 | Kimura et al. | Jun 2010 | B2 |
7753858 | Starksen et al. | Jul 2010 | B2 |
7753922 | Starksen | Jul 2010 | B2 |
7753924 | Starksen et al. | Jul 2010 | B2 |
7758637 | Starksen et al. | Jul 2010 | B2 |
7766812 | Schroeder et al. | Aug 2010 | B2 |
7850600 | Piskun | Dec 2010 | B1 |
7883538 | To et al. | Feb 2011 | B2 |
7918787 | Saadat | Apr 2011 | B2 |
7922762 | Starksen | Apr 2011 | B2 |
7993368 | Gambale et al. | Aug 2011 | B2 |
8066766 | To et al. | Nov 2011 | B2 |
8287555 | Starksen et al. | Oct 2012 | B2 |
8287557 | To et al. | Oct 2012 | B2 |
8343173 | Starksen et al. | Jan 2013 | B2 |
8641727 | Starksen et al. | Feb 2014 | B2 |
9072513 | To et al. | Jul 2015 | B2 |
9226825 | Starksen et al. | Jan 2016 | B2 |
9468528 | Starksen et al. | Oct 2016 | B2 |
9636106 | Meier et al. | May 2017 | B2 |
9861350 | Senna et al. | Jan 2018 | B2 |
9949829 | Starksen et al. | Apr 2018 | B2 |
10092402 | Starksen et al. | Oct 2018 | B2 |
20010005787 | Oz et al. | Jun 2001 | A1 |
20010014800 | Frazier et al. | Aug 2001 | A1 |
20010023332 | Hahnen | Sep 2001 | A1 |
20010031979 | Ricci | Oct 2001 | A1 |
20010034528 | Foerster et al. | Oct 2001 | A1 |
20010041821 | Wilk | Nov 2001 | A1 |
20020013571 | Goldfarb et al. | Jan 2002 | A1 |
20020013621 | Stobie et al. | Jan 2002 | A1 |
20020026201 | Foerster et al. | Feb 2002 | A1 |
20020029080 | Mortier et al. | Mar 2002 | A1 |
20020035361 | Houser et al. | Mar 2002 | A1 |
20020042621 | Liddicoat et al. | Apr 2002 | A1 |
20020065536 | Hart et al. | May 2002 | A1 |
20020072757 | Ahmed et al. | Jun 2002 | A1 |
20020077524 | Schweich, Jr. et al. | Jun 2002 | A1 |
20020087048 | Brock et al. | Jul 2002 | A1 |
20020087049 | Brock et al. | Jul 2002 | A1 |
20020087148 | Brock et al. | Jul 2002 | A1 |
20020087169 | Brock et al. | Jul 2002 | A1 |
20020095167 | Liddicoat et al. | Jul 2002 | A1 |
20020095175 | Brock et al. | Jul 2002 | A1 |
20020138044 | Streeter et al. | Sep 2002 | A1 |
20020156526 | Hlavka et al. | Oct 2002 | A1 |
20020161378 | Downing | Oct 2002 | A1 |
20020165486 | Bertolero et al. | Nov 2002 | A1 |
20020173841 | Ortiz et al. | Nov 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20020183835 | Taylor et al. | Dec 2002 | A1 |
20020193815 | Foerster et al. | Dec 2002 | A1 |
20030009196 | Peterson | Jan 2003 | A1 |
20030014060 | Wilson | Jan 2003 | A1 |
20030018358 | Saadat | Jan 2003 | A1 |
20030032979 | Mortier et al. | Feb 2003 | A1 |
20030033006 | Phillips et al. | Feb 2003 | A1 |
20030060813 | Loeb et al. | Mar 2003 | A1 |
20030069593 | Tremulis et al. | Apr 2003 | A1 |
20030074012 | Nguyen et al. | Apr 2003 | A1 |
20030078465 | Pai et al. | Apr 2003 | A1 |
20030078601 | Shikhman et al. | Apr 2003 | A1 |
20030078603 | Schaller et al. | Apr 2003 | A1 |
20030093118 | Ho et al. | May 2003 | A1 |
20030105520 | Alferness et al. | Jun 2003 | A1 |
20030125739 | Bagga et al. | Jul 2003 | A1 |
20030125767 | Collier et al. | Jul 2003 | A1 |
20030130731 | Vidlund et al. | Jul 2003 | A1 |
20030144697 | Mathis et al. | Jul 2003 | A1 |
20030158464 | Bertolero | Aug 2003 | A1 |
20030158581 | Levinson | Aug 2003 | A1 |
20030167062 | Gambale et al. | Sep 2003 | A1 |
20030167071 | Martin et al. | Sep 2003 | A1 |
20030181800 | Bonutti | Sep 2003 | A1 |
20030181926 | Dana et al. | Sep 2003 | A1 |
20030199974 | Lee et al. | Oct 2003 | A1 |
20030220685 | Hlvaka et al. | Nov 2003 | A1 |
20030225420 | Wardle | Dec 2003 | A1 |
20030233105 | Gayton | Dec 2003 | A1 |
20030233142 | Morales et al. | Dec 2003 | A1 |
20030236535 | Onuki et al. | Dec 2003 | A1 |
20040003819 | St. Goar et al. | Jan 2004 | A1 |
20040019378 | Hlavka et al. | Jan 2004 | A1 |
20040024414 | Downing | Feb 2004 | A1 |
20040030382 | St. Goar et al. | Feb 2004 | A1 |
20040039442 | St. Goar et al. | Feb 2004 | A1 |
20040044365 | Bachman | Mar 2004 | A1 |
20040092962 | Thornton et al. | May 2004 | A1 |
20040093023 | Allen et al. | May 2004 | A1 |
20040093024 | Lousararian et al. | May 2004 | A1 |
20040097788 | Mourlas et al. | May 2004 | A1 |
20040122450 | Oren et al. | Jun 2004 | A1 |
20040152947 | Schroeder et al. | Aug 2004 | A1 |
20040172046 | Hlavka et al. | Sep 2004 | A1 |
20040181238 | Zarbatany et al. | Sep 2004 | A1 |
20040186378 | Gesswein | Sep 2004 | A1 |
20040193191 | Starksen et al. | Sep 2004 | A1 |
20040204724 | Kissel et al. | Oct 2004 | A1 |
20040210238 | Nobles et al. | Oct 2004 | A1 |
20040236372 | Anspach, III et al. | Nov 2004 | A1 |
20040236419 | Milo | Nov 2004 | A1 |
20040243227 | Starksen et al. | Dec 2004 | A1 |
20040260317 | Bloom et al. | Dec 2004 | A1 |
20050021054 | Ainsworth et al. | Jan 2005 | A1 |
20050055052 | Lombardo et al. | Mar 2005 | A1 |
20050055087 | Starksen | Mar 2005 | A1 |
20050065550 | Starksen et al. | Mar 2005 | A1 |
20050065589 | Schneider et al. | Mar 2005 | A1 |
20050075723 | Schroeder et al. | Apr 2005 | A1 |
20050080454 | Drews et al. | Apr 2005 | A1 |
20050107810 | Morales et al. | May 2005 | A1 |
20050107811 | Starksen et al. | May 2005 | A1 |
20050107871 | Realyvasquez et al. | May 2005 | A1 |
20050119523 | Starksen et al. | Jun 2005 | A1 |
20050119673 | Gordon et al. | Jun 2005 | A1 |
20050119734 | Spence et al. | Jun 2005 | A1 |
20050137689 | Salahieh et al. | Jun 2005 | A1 |
20050177180 | Kaganov | Aug 2005 | A1 |
20050184122 | Hlavka et al. | Aug 2005 | A1 |
20050192599 | Demarais | Sep 2005 | A1 |
20050192629 | Saadat et al. | Sep 2005 | A1 |
20050197694 | Pai et al. | Sep 2005 | A1 |
20050209690 | Mathis et al. | Sep 2005 | A1 |
20050216078 | Starksen et al. | Sep 2005 | A1 |
20050228448 | Li | Oct 2005 | A1 |
20050228452 | Mourlas et al. | Oct 2005 | A1 |
20050251157 | Saadat et al. | Nov 2005 | A1 |
20050251159 | Ewers et al. | Nov 2005 | A1 |
20050251166 | Vaughan et al. | Nov 2005 | A1 |
20050251177 | Saadat et al. | Nov 2005 | A1 |
20050251205 | Ewers et al. | Nov 2005 | A1 |
20050251207 | Flores et al. | Nov 2005 | A1 |
20050251208 | Elmer et al. | Nov 2005 | A1 |
20050251209 | Saadat et al. | Nov 2005 | A1 |
20050251210 | Westra et al. | Nov 2005 | A1 |
20050267495 | Ginn et al. | Dec 2005 | A1 |
20050273138 | To et al. | Dec 2005 | A1 |
20050277966 | Ewers et al. | Dec 2005 | A1 |
20050277981 | Maahs et al. | Dec 2005 | A1 |
20050277983 | Saadat et al. | Dec 2005 | A1 |
20060015144 | Burbank et al. | Jan 2006 | A1 |
20060025750 | Starksen et al. | Feb 2006 | A1 |
20060025784 | Starksen et al. | Feb 2006 | A1 |
20060025787 | Morales et al. | Feb 2006 | A1 |
20060058817 | Starksen et al. | Mar 2006 | A1 |
20060069429 | Spence et al. | Mar 2006 | A1 |
20060122633 | To et al. | Jun 2006 | A1 |
20060129188 | Starksen et al. | Jun 2006 | A1 |
20060161040 | McCarthy et al. | Jul 2006 | A1 |
20060178682 | Boehlke | Aug 2006 | A1 |
20060184203 | Martin et al. | Aug 2006 | A1 |
20060190030 | To et al. | Aug 2006 | A1 |
20060264975 | Pipenhagen et al. | Nov 2006 | A1 |
20060271101 | Saadat et al. | Nov 2006 | A1 |
20060282161 | Huynh et al. | Dec 2006 | A1 |
20060287661 | Bolduc et al. | Dec 2006 | A1 |
20070005081 | Findlay, III et al. | Jan 2007 | A1 |
20070005394 | Bleyendaal et al. | Jan 2007 | A1 |
20070010857 | Sugimoto et al. | Jan 2007 | A1 |
20070032820 | Chin-Chen et al. | Feb 2007 | A1 |
20070038293 | St. Goar et al. | Feb 2007 | A1 |
20070049942 | Hindrichs et al. | Mar 2007 | A1 |
20070051377 | Douk et al. | Mar 2007 | A1 |
20070055206 | To et al. | Mar 2007 | A1 |
20070112244 | McCarthy et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070112424 | Spence et al. | May 2007 | A1 |
20080045977 | To et al. | Feb 2008 | A1 |
20080045982 | To et al. | Feb 2008 | A1 |
20080045983 | To et al. | Feb 2008 | A1 |
20080051810 | To et al. | Feb 2008 | A1 |
20080051832 | To et al. | Feb 2008 | A1 |
20080051837 | To et al. | Feb 2008 | A1 |
20080058765 | Jais et al. | Mar 2008 | A1 |
20080058868 | To et al. | Mar 2008 | A1 |
20080172035 | Starksen et al. | Jul 2008 | A1 |
20080228032 | Starksen et al. | Sep 2008 | A1 |
20080234701 | Morales et al. | Sep 2008 | A1 |
20080234702 | Morales et al. | Sep 2008 | A1 |
20080234704 | Starksen et al. | Sep 2008 | A1 |
20080234728 | Starksen et al. | Sep 2008 | A1 |
20080234815 | Starksen | Sep 2008 | A1 |
20080243150 | Starksen et al. | Oct 2008 | A1 |
20080294177 | To et al. | Nov 2008 | A1 |
20090182417 | Tremulis et al. | Jul 2009 | A1 |
20090222083 | Nguyen et al. | Sep 2009 | A1 |
20090234318 | Loulmet et al. | Sep 2009 | A1 |
20090276038 | Tremulis et al. | Nov 2009 | A1 |
20100023117 | Yoganathan et al. | Jan 2010 | A1 |
20100049213 | Serina et al. | Feb 2010 | A1 |
20100076548 | Konno | Mar 2010 | A1 |
20100082098 | Starksen et al. | Apr 2010 | A1 |
20100094314 | Hernlund et al. | Apr 2010 | A1 |
20100121349 | Meier et al. | May 2010 | A1 |
20110098743 | Lyons et al. | Apr 2011 | A1 |
20110160528 | Starksen | Jun 2011 | A1 |
20110276091 | Melanson et al. | Nov 2011 | A1 |
20120101442 | Legaspi et al. | Apr 2012 | A1 |
20120271331 | To et al. | Oct 2012 | A1 |
20130190863 | Call et al. | Jul 2013 | A1 |
20130304093 | Serina et al. | Nov 2013 | A1 |
20140135799 | Henderson | May 2014 | A1 |
20140148849 | Eugene et al. | May 2014 | A1 |
20140155783 | Starksen et al. | Jun 2014 | A1 |
20140188140 | Meier et al. | Jul 2014 | A1 |
20140194976 | Starksen et al. | Jul 2014 | A1 |
20140303649 | Nguyen et al. | Oct 2014 | A1 |
20150164639 | Starksen et al. | Jun 2015 | A1 |
20150182216 | Morales et al. | Jul 2015 | A1 |
20170224489 | Starksen et al. | Aug 2017 | A1 |
20180140421 | Sampson et al. | May 2018 | A1 |
Number | Date | Country |
---|---|---|
0 363 661 | Apr 1990 | EP |
0 669 101 | Aug 1995 | EP |
1370546 | Oct 1974 | GB |
6-510460 | Nov 1994 | JP |
11-506628 | Jun 1999 | JP |
2004-601 | Jan 2004 | JP |
2007-514455 | Jun 2007 | JP |
48-23295 | Nov 2011 | JP |
WO 9308740 | May 1993 | WO |
WO 9403227 | Feb 1994 | WO |
WO 9515715 | Jun 1995 | WO |
WO 9608208 | Mar 1996 | WO |
WO 9639081 | Dec 1996 | WO |
WO 9639942 | Dec 1996 | WO |
WO 9727799 | Aug 1997 | WO |
WO 9727807 | Aug 1997 | WO |
WO 9730639 | Aug 1997 | WO |
WO 9807375 | Feb 1998 | WO |
WO 0060995 | Oct 2000 | WO |
WO 0060995 | Oct 2000 | WO |
WO 0067640 | Nov 2000 | WO |
WO 0067640 | Nov 2000 | WO |
WO 0126586 | Apr 2001 | WO |
WO 0154618 | Aug 2001 | WO |
WO 0203892 | Jan 2002 | WO |
WO-200234167 | May 2002 | WO |
WO-200234167 | May 2002 | WO |
WO 02051329 | Jul 2002 | WO |
WO-02053011 | Jul 2002 | WO |
WO-02053011 | Jul 2002 | WO |
WO 02085251 | Oct 2002 | WO |
WO 02085252 | Oct 2002 | WO |
WO 03053289 | Jul 2003 | WO |
WO 03088875 | Oct 2003 | WO |
WO 03105667 | Dec 2003 | WO |
WO 03105667 | Dec 2003 | WO |
WO 03105670 | Dec 2003 | WO |
WO 03105670 | Dec 2003 | WO |
WO 2004037317 | May 2004 | WO |
WO 2004037317 | May 2004 | WO |
WO 2004082523 | Sep 2004 | WO |
WO 2004082523 | Sep 2004 | WO |
WO 2004082538 | Sep 2004 | WO |
WO 2004082538 | Sep 2004 | WO |
WO 2005025644 | Mar 2005 | WO |
WO 2005025644 | Mar 2005 | WO |
WO 2005062931 | Jul 2005 | WO |
WO 2005062931 | Jul 2005 | WO |
WO 2005102181 | Nov 2005 | WO |
WO 2006037073 | Apr 2006 | WO |
WO 2006097931 | Sep 2006 | WO |
WO 2006097931 | Sep 2006 | WO |
WO 2006116558 | Nov 2006 | WO |
WO 2006116558 | Nov 2006 | WO |
WO 2006116558 | Nov 2006 | WO |
WO 2007001936 | Jan 2007 | WO |
WO 2007005495 | Jan 2007 | WO |
WO 2007021564 | Feb 2007 | WO |
WO 2007021834 | Feb 2007 | WO |
WO 2007035449 | Mar 2007 | WO |
WO 2007056502 | May 2007 | WO |
WO 2007100409 | Sep 2007 | WO |
WO 2007001936 | Oct 2007 | WO |
WO 2008028135 | Mar 2008 | WO |
WO 2008028135 | Mar 2008 | WO |
WO-2012031204 | Mar 2012 | WO |
WO-2012031204 | Mar 2012 | WO |
WO-2018094258 | May 2018 | WO |
WO 2018094258 | May 2018 | WO |
Entry |
---|
De Simone, R. et al. (Apr. 15, 1993). “Adjustable Tricuspid Valve Annuloplasty Assisted by Intraoperative Transesophageal Color Doppler Echocardiography,” Am. J. Cardiol. 71(11):926-931. |
De Simone, R. et al. (Apr. 1, 1994). “Adjustable Annuloplasty for Tricuspid Insufficiency with External Control,” Reader's Comments and Reply, Am. J. Cardiol. 73(9):721-722. |
Downing, S.W. et al. (2002). “Feasibility of Off-Pump ASD Closure Using Real-Time 3-D Echocardiography,” The Heart Surgery Forum 5(2):96-99, Abstract 7025. |
European Examination Communication dated Dec. 8, 2009, for EP Application No. 06 837 222.6 filed on Nov. 8, 2006, three pages. |
Extended European Search Report dated Sep. 9, 2011, for EP Patent Application No. 11158896.8, filed on Sep. 1, 2004, 7 pages. |
Extended European Search Report dated Sep. 16, 2011, for EP Patent Application No. 11158898.4, filed on Sep. 1, 2004, 8 pages. |
Final Office Action dated Feb. 6, 2007, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 8 pages. |
Final Office Action dated Jul. 12, 2007, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages. |
Final Office Action dated Jul. 24, 2007, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 10 pages. |
Final Office Action dated Aug. 6, 2007, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 12 pages. |
Final Office Action dated Aug. 6, 2007, for U.S. Appl. No. 11/137,833, filed May 24, 2005, 8 pages. |
Final Office Action dated Aug. 13, 2007, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 9 pages. |
Final Office Action dated Aug. 14, 2007, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 8 pages. |
Final Office Action dated Aug. 30, 2007, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 9 pages. |
Final Office Action dated Oct. 30, 2007, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 6 pages. |
Final Office Action dated Apr. 2, 2008, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 15 pages. |
Final Office Action dated Apr. 14, 2008, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 11 pages. |
Final Office Action dated May 28, 2008, for U.S. Appl. No. 11/270,034, filed Nov. 8. 2005, 10 pages. |
Final Office Action dated Jun. 4, 2008, for U.S. Appl. No. 11/202,474, filed Aug. 11. 2005, 10 pages. |
Final Office Action dated Aug. 1, 2008, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages. |
Final Office Action dated Sep. 30, 2008, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 7 pages. |
Final Office Action dated Oct. 14, 2008, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Final Office Action dated Jan. 22, 2009, for U.S. Appl. No. 11/255,400, filed Oct. 20. 2005, 9 pages. |
Final Office Action dated Mar. 11, 2009, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 10 pages. |
Final Office Action dated Apr. 10, 2009, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 8 pages. |
Final Office Action dated Apr. 10, 2009, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 8 pages. |
Final Office Action dated Apr. 27, 2009, for U.S. Appl. No. 10/901,455, filed Jul. 27, 2004, 11 pages. |
Final Office Action dated Apr. 29, 2009, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 9 pages. |
Final Office Action dated Jul. 21, 2009, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages. |
Final Office Action dated Sep. 2, 2009, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages. |
Final Office Action dated Sep. 28, 2009, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages. |
Final Office Action dated Oct. 13, 2009, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 11 pages. |
Final Office Action dated Nov. 10, 2009, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Final Office Action dated Mar. 3, 2010, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 7 pages. |
Final Office Action dated Mar. 25, 2010, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 8 pages. |
Final Office Action dated Jun. 8, 2010, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 17 pages. |
Final Office Action dated Jul. 26, 2010, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages. |
Final Office Action dated Sep. 15, 2010, for U.S. Appl. No. 11/894,401, filed Aug. 20, 2007, 6 pages. |
Final Office Action dated Oct. 6, 2010, for U.S. Appl. No. 12/132,375, filed Jun. 3, 2008, 9 pages. |
Final Office Action dated Nov. 26, 2010, for U.S. Appl. No. 11/894,340, filed Aug. 20, 2007, 12 pages. |
Final Office Action dated Nov. 29, 2010, for U.S. Appl. No. 11/894,463, filed Aug. 20, 2007, 12 pages. |
Final Office Action dated Feb. 24, 2011, for U.S. Appl. No. 11/894,397, filed Aug. 20, 2007, 12 pages. |
Final Office Action dated Feb. 24, 2011, for U.S. Appl. No. 11/894,468, filed Aug. 20, 2007, 12 pages. |
Final Office Action dated Mar. 17, 2011, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 13 pages. |
Final Office Action dated Mar. 17, 2011, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 9 pages. |
Final Office Action dated Apr. 20, 2011, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 8 pages. |
Final Office Action dated Aug. 4, 2011, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 9 pages. |
Final Office Action dated Nov. 3, 2011, for U.S. Appl. No. 12/581,040, filed Oct. 16, 2009, 5 pages. |
Final Office Action dated Nov. 10, 2011, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 20 pages. |
Final Office Action dated Dec. 6, 2011, for U.S. Appl. No. 12/366,553, filed Feb. 5, 2009, 7 pages. |
Final Office Action dated Mar. 19, 2012, for U.S. Appl. No. 12/574,563, filed Oct. 6, 2009, 6 pages. |
Final Office Action dated Jun. 11, 2012, for U.S. Appl. No. 12/132,161, filed Jun. 3, 2008, 13 pages. |
Final Office Action dated Feb. 5, 2015, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 10 pages. |
Final Office Action dated Jun. 11, 2012, for U.S. Appl. No. 12/187,331, filed Jun. 6, 2008, 7 pages. |
Final Office Action dated Dec. 26, 2014, for U.S. Appl. No. 13/820,447, filed Oct. 18, 2013, 8 pages. |
Final Office Action dated May 15, 2015, for U.S. Appl. No. 13/820,447, filed Oct. 18, 2013, 11 pages. |
Final Office Action dated Feb. 4, 2016, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 9 pages. |
Final Office Action dated May 19, 2016, for U.S. Appl. No. 13/820,447, filed Oct. 18, 2013, 10 pages. |
Final Office Action dated Sep. 14, 2017, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 8 pages. |
Final Office Action dated Nov. 3, 2017, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 10 pages. |
International Search Report dated Dec. 19, 2006, for PCT Application No. PCT/US2006/031190, filed Aug. 10, 2006, four pages. |
International Search Report dated Apr. 2, 2007, for PCT Application No. PCT/US2006/043597, filed Nov. 8, 2006, 7 pages. |
International Search Report dated Feb. 21, 2012, for PCT Patent Application No. PCT/US2011/050331, filed on Sep. 2, 2011, 4 pages. |
International Search Report dated Mar. 7, 2007, for PCT Patent Application No. PCT/US2004/028431, filed on Sep. 1, 2004, 1 page. |
Nagy, Z.L. et al. (Dec. 2000). “Mitral Annuloplasty with a Suture Technique,” European Journal of Cardio-thoracic Surgery 18(6):739-740. |
Non-Final Office Action dated Aug. 9, 2006, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 17 pages. |
Non-Final Office Action dated Aug. 22, 2006, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 6 pages. |
Non-Final Office Action dated Nov. 15, 2006, for U.S. Appl. No. 11/137,833, filed May 24, 2005, 12 pages. |
Non-Final Office Action dated Nov. 28, 2006, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 20 pages. |
Non-Final Office Action dated Dec. 27, 2006, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Non-Final Office Action dated Dec. 27, 2006, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages. |
Non-Final Office Action dated Jan. 4, 2007, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 7 pages. |
Non-Final Office Action dated Feb. 27, 2007, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005. 8 pages. |
Non-Final Office Action dated Mar. 12, 2007, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 11 pages. |
Non-Final Office Action dated Jul. 24, 2007, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 6 pages. |
Non-Final Office Action dated Aug. 1, 2007, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 16 pages. |
Non-Final Office Action dated Aug. 30, 2007, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 10 pages. |
Non-Final Office Action dated Oct. 19, 2007, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 7 pages. |
Non-Final Office Action dated Oct. 29, 2007, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 10 pages. |
Non-Final Office Action dated Nov. 14, 2007, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 8 pages. |
Non-Final Office Action dated Nov. 14, 2007, for U.S. Appl. No. 11/137,833, filed May 24, 2005, 8 pages. |
Non-Final Office Action dated Jan. 9, 2008, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages. |
Non-Final Office Action dated Jan. 31, 2008, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 7 pages. |
Non-Final Office Action (Supplementary) dated May 9, 2008, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 7 pages. |
Non-Final Office Action dated Mar. 27, 2008, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 7 pages. |
Non-Final Office Action dated Apr. 29, 2008, for U.S. Appl. No. 10/901,455, filed Jul. 27, 2004, 9 pages. |
Non-Final Office Action dated Jun. 6, 2008, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 5 pages. |
Non-Final Office Action dated Aug. 29, 2008, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 15 pages. |
Non-Final Office Action dated Sep. 26, 2008, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 11 pages. |
Non-Final Office Action dated Oct. 24, 2008, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 11 pages. |
Non-Final Office Action dated Jan. 13, 2009, for U.S. Appl. No. 10/901,555, filed Jul. 27, 2004, 11 pages. |
Non-Final Office Action dated Jan. 23, 2009, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages. |
Non-Final Office Action dated Jan. 23, 2009, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages. |
Non-Final Office Action dated Jan. 29, 2009, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 6 pages. |
Non-Final Office Action dated Mar. 5, 2009, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages. |
Non-Final Office Action dated Mar. 18, 2009, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 12 pages. |
Non-Final Office Action dated Mar. 27, 2009, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Non-Final Office Action dated Mar. 31, 2009, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 15 pages. |
Non-Final Office Action dated Aug. 25, 2009, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 7 pages. |
Non-Final Office Action dated Aug. 26, 2009, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 6 pages. |
Non-Final Office Action dated Sep. 17, 2009, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 13 pages. |
Non-Final Office Action dated Oct. 8, 2009, for U.S. Appl. No. 10/901,455, filed Jul. 27, 2004, 10 pages. |
Non-Final Office Action dated Oct. 19, 2009, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 21 pages. |
Non-Final Office Action dated Jan. 19, 2010, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 10 pages. |
Non-Final Office Action dated Feb. 18, 2010, for U.S. Appl. No. 11/894,401, filed Aug. 20, 2007, 6 pages. |
Non-Final Office Action dated Mar. 16, 2010, for U.S. Appl. No. 11/894,340, filed Aug. 20, 2007, 14 pages. |
Non-Final Office Action dated Mar. 29, 2010, for U.S. Appl. No. 11/894,463, filed Aug. 20, 2007, 14 pages. |
Non-Final Office Action dated Apr. 2, 2010, for U.S. Appl. No. 12/132,375, filed Jun. 3, 2008, 9 pages. |
Non-Final Office Action dated Jun. 9, 2010, for U.S. Appl. No. 11/894,468, filed Aug. 20, 2007, 14 pages. |
Non-Final Office Action dated Jun. 21, 2010, for U.S. Appl. No. 11/894,397, filed Aug. 20, 2007, 13 pages. |
Non-Final Office Action dated Aug. 17, 2010, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 7 pages. |
Non-Final Office Action dated Aug. 20, 2010, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 13 pages. |
Non-Final Office Action dated Oct. 8, 2010, for U.S. Appl. No. 11/894,368, filed Aug. 20, 2007, 10 pages. |
Non-Final Office Action dated Oct. 25, 2010, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 8 pages. |
Non-Final Office Action dated Oct. 29, 2010, for U.S. Appl. No. 11/894,530, filed Aug. 20, 2007, 11 pages. |
Non-Final Office Action dated Nov. 24, 2010, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 8 pages. |
Non-Final Office Action dated Feb. 2, 2011, for U.S. Appl. No. 12/581,040, filed Oct. 16, 2009, 5 pages. |
Non-Final Office Action dated Apr. 27, 2011, for U.S. Appl. No. 12/366,533, filed Feb. 5, 2009, 9 pages. |
Non-Final Office Action dated Jul. 29, 2011, for U.S. Appl. No. 12/574,563, filed Oct. 6, 2009, 5 pages. |
Non-Final Office Action dated Oct. 13, 2011, for U.S. Appl. No. 12/187,331, filed Aug. 6, 2008, 5 pages. |
Non-Final Office Action dated Oct. 18, 2011, for U.S. Appl. No. 12/132,161, filed Jun. 3, 2008, 15 pages. |
Non-Final Office Action dated Oct. 18, 2011, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Non-Final Office Action dated Oct. 20, 2011, for U.S. Appl. No. 12/824,051, filed Jun. 25, 2010, 8 pages. |
Non-Final Office Action dated Dec. 22, 2011, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 9 pages. |
Non-Final Office Action dated Jun. 7, 2012, for U.S. Appl. No. 12/850,531, filed Aug. 4, 2010, 8 pages. |
Non-Final Office Action dated Apr. 8, 2013, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 9 pages. |
Non-Final Office Action dated Nov. 7, 2014, for U.S. Appl. No. 12/187,331, filed Aug. 6, 2008, 8 pages. |
Non-Final Office Action dated Nov. 24, 2015, for U.S. Appl. No. 14/156,347, filed Jan. 15, 2014, 5 pages. |
Non-Final Office Action dated Apr. 21, 2016, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 12 pages. |
Non-Final Office Action dated Jan. 26, 2017, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 10 pages. |
Non-Final Office Action dated Feb. 17, 2017, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 11 pages. |
Non-Final Office Action dated Feb. 17, 2017, for U.S. Appl. No. 13/820,447, filed Oct. 18, 2013, 11 pages. |
Non-Final Office Action dated Jun. 12, 2018, for U.S. Appl. No. 13/948,009, filed Jul. 22, 2013, 23 pages. |
Notice of Allowance dated Aug. 4, 2009, for U.S. Appl. No. 10/901,555, filed Jul. 27, 2004, 7 pages. |
Notice of Allowance dated Feb. 24, 2010, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 10 pages. |
Notice of Allowance dated Apr. 28, 2010, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 7 pages. |
Notice of Allowance dated May 5, 2010, for U.S. Appl. No. 10/901,455, filed Jul. 27, 2004, 8 pages. |
Notice of Allowance dated Nov. 17, 2010, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 11 pages. |
Notice of Allowance dated Dec. 6, 2010, for U.S. Appl. No. 12/132,375, filed Jun. 3, 2008, 9 pages. |
Notice of Allowance dated Jul. 26, 2011, for U.S. Appl. No. 11/894,530, filed Aug. 20, 2007, 10 pages. |
Notice of Allowance dated Jun. 11, 2012, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Notice of Allowance dated Sep. 25, 2013, for U.S. Appl. No. 12/132,161, filed Jun. 3, 2008, 12 pages. |
Notice of Allowance dated Jun. 15, 2016, for U.S. Appl. No. 14/156,347, filed Jan. 15, 2014, 7 pages. |
Notice of Allowance dated Oct. 29, 2015, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 8 pages. |
Notice of Allowance dated Mar. 2, 2015, for U.S. Appl. No. 12/187,331, filed Aug. 6, 2008, 5 pages. |
Notice of Allowance dated Nov. 8, 2017, for U.S. Appl. No. 13/820,447, filed Oct. 18, 2013, 8 pages. |
Notice of Allowance dated Dec. 19, 2017, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 8 pages. |
Notice of Allowance dated Jun. 22, 2018, for U.S. Appl. No. 15/265,781, filed Sep. 14, 2016, 8 pages. |
Shumway, S.J. et al. (Dec. 1988). “A ‘Designer’ Annuloplasty Ring for Patients with Massive Mitral Annular Dilatation,” Ann. Thorac. Surg. 46(6):695-696. |
Supplementary European Search Report dated Nov. 10, 2008, for EP Application No. 04 782 847.0, filed on Sep. 1, 2004, 2 pages. |
Written Opinion of the International Searching Authority dated Feb. 21, 2012, for PCT Patent Application No. PCT/US2011/050331, filed on Sep. 2, 2011, 4 pages. |
Written Opinion of the International Searching Authority dated Mar. 7, 2007, for PCT Patent Application No. PCT/US2004/028431, filed on Sep. 1, 2004, 4 pages. |
Written Opinion of the International Searching Authority dated Dec. 19, 2006, for PCT Application No. PCT/US2006/031190, filed Aug. 10, 2006, 6 pages. |
Written Opinion of the International Searching Authority dated Apr. 2, 2007, for PCT Application No. PCT/US2006/043597, filed Nov. 8, 2006, 7 pages. |
Corbion Purac (2015). Technology Summary, 1 total page. |
Corbion Purac (2015). Purasorb® Polymers: Products for Medical Devices, 2 total pages. |
International Search Report dated Mar. 8, 2018, for PCT Patent Application No. PCT/US2017/062382, filed on Nov. 17, 2017, 4 pages. |
Saito, E. et al. (2010). “Experimental and computational characterization of designed and fabricated 50:50 PLGA porous scaffolds for human trabecular bone applications,” J. Mater Sci. Mater Med. 21:2371-2383. |
Written Opinion of the International Searching Authority dated Mar. 8, 2018, for PCT Patent Application No. PCT/US2017/062382, filed on Nov. 17, 2017, 10 pages. |
Extended European Search Report dated Dec. 12, 2018, for EP Patent Application No. 18170269.7, filed on Sep. 1, 2004, 7 pages. |
Extended European Search Report dated Dec. 3, 2018, for EP Patent Application No. 18167829.3, filed on Oct. 16, 2007, 8 pages. |
Notice of Allowance dated Jun. 22, 2018, for U.S. Appl. No. 15/265,781, filed Sep. 14, 2016, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20180228609 A1 | Aug 2018 | US |
Number | Date | Country | |
---|---|---|---|
60524922 | Nov 2003 | US | |
60459735 | Apr 2003 | US | |
60462502 | Feb 2003 | US | |
60445890 | Feb 2003 | US | |
60429288 | Nov 2002 | US | |
60388935 | Jun 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14626826 | Feb 2015 | US |
Child | 15955564 | US | |
Parent | 10901554 | Jul 2004 | US |
Child | 14626826 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10792681 | Mar 2004 | US |
Child | 10901554 | US | |
Parent | 10741130 | Dec 2003 | US |
Child | 10792681 | US | |
Parent | 10656797 | Sep 2003 | US |
Child | 10741130 | US | |
Parent | 10461043 | Jun 2003 | US |
Child | 10656797 | US |